Company: FENC
Filing Date: 2025-11-19
Form Type: 8-K
Source: 0001104659-25-113915
Chunk: 1

Company: FENNEC PHARMACEUTICALS INC.
Filing Date: 2025-11-19
Form: 8-K
Item: Item 8.01
Chunk 1
---
Item 8.01      Other Events.  

On
November 19, 2025, the Company issued a news release announcing the repurchase and redemption in full of the Remaining Notes as described
under Item 1.01 of this Current Report on Form 8-K. A copy of the news release is attached as Exhibit 99.1 to this Current Report on Form
8-K.

The information contained in
this Item 8.01, as well as Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18
of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), nor shall it be deemed incorporated by reference
in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference
in such a filing.